These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8684993)
1. [Calcium-phosphorus metabolism in celiac disease in children]. Praticò G; Caltabiano L; Bottaro G; Palano GM; Rotolo N; Spina M Pediatr Med Chir; 1995; 17(5):403-6. PubMed ID: 8684993 [TBL] [Abstract][Full Text] [Related]
2. Intestinal calcium absorption as shown by stable strontium test in celiac disease before and after gluten-free diet. Molteni N; Bardella MT; Vezzoli G; Pozzoli E; Bianchi P Am J Gastroenterol; 1995 Nov; 90(11):2025-8. PubMed ID: 7485015 [TBL] [Abstract][Full Text] [Related]
3. Bone metabolism in celiac disease. Zanchi C; Di Leo G; Ronfani L; Martelossi S; Not T; Ventura A J Pediatr; 2008 Aug; 153(2):262-5. PubMed ID: 18534236 [TBL] [Abstract][Full Text] [Related]
4. [Calcium phosphate metabolism in thalassemia]. Praticò G; Di Gregorio F; Caltabiano L; Palano GM; Caruso-Nicoletti M Pediatr Med Chir; 1998; 20(4):265-8. PubMed ID: 9866849 [TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
6. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. Salusky IB; Goodman WG; Sahney S; Gales B; Perilloux A; Wang HJ; Elashoff RM; Jüppner H J Am Soc Nephrol; 2005 Aug; 16(8):2501-8. PubMed ID: 15944337 [TBL] [Abstract][Full Text] [Related]
8. [Mineral content in bones of children with symptomless celiac disease and gluten-free diet]. Szathmári M; Tulassay T; Arató A; Bodánszky H; Szabó A; Tulassay Z Orv Hetil; 1997 Dec; 138(51):3233-8. PubMed ID: 9454102 [TBL] [Abstract][Full Text] [Related]
9. Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency. Soliman AT; Al Khalaf F; Alhemaidi N; Al Ali M; Al Zyoud M; Yakoot K Metabolism; 2008 Jan; 57(1):95-102. PubMed ID: 18078865 [TBL] [Abstract][Full Text] [Related]
10. Role of change in vitamin D metabolism with age in calcium and phosphorus metabolism in normal human subjects. Fujisawa Y; Kida K; Matsuda H J Clin Endocrinol Metab; 1984 Oct; 59(4):719-26. PubMed ID: 6541227 [TBL] [Abstract][Full Text] [Related]
11. Interaction between the levels of hormones and minerals in sera of healthy and sick cows. Bandzaite V; Klimiene I; Spakauskas V; Matusevicius A Pol J Vet Sci; 2005; 8(4):269-74. PubMed ID: 16385850 [TBL] [Abstract][Full Text] [Related]
12. [Phosphorus-calcium metabolism and plasma 25-hydroxycholecalciferol in intestinal malabsorption]. Bozio AM; Paunier L; Nusslé D; Sizonenko PC Helv Paediatr Acta; 1980 Sep; 35(4):313-23. PubMed ID: 7451235 [TBL] [Abstract][Full Text] [Related]
13. Effect of magnesium on phosphorus and calcium metabolism. Paunier L Monatsschr Kinderheilkd; 1992 Sep; 140(9 Suppl 1):S17-20. PubMed ID: 1331782 [TBL] [Abstract][Full Text] [Related]
14. The 2002 Moyer Award. Metabolic effects of vitamin D on serum calcium, magnesium, and phosphorus in pediatric burn patients. Wray CJ; Mayes T; Khoury J; Warden GD; Gottschlich M J Burn Care Rehabil; 2002; 23(6):416-23. PubMed ID: 12432318 [TBL] [Abstract][Full Text] [Related]
15. Effect of treatment on bone mass, mineral metabolism, and body composition in untreated celiac disease patients. Mautalen C; González D; Mazure R; Vázquez H; Lorenzetti MP; Maurino E; Niveloni S; Pedreira S; Smecuol E; Boerr LA; Bai JC Am J Gastroenterol; 1997 Feb; 92(2):313-8. PubMed ID: 9040213 [TBL] [Abstract][Full Text] [Related]
16. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges. Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962 [TBL] [Abstract][Full Text] [Related]